Weiyi Li

机构：Chinese Center For Disease Control and Prevention, National Health and Family Planning Commission, Oklahoma City University, Shanghai Huangpu District Central Hospital, University of Oklahoma · ORCID：0000-0002-9988-797X

发表论文 55 篇 · 总被引 289 次 · h-index 8

代表论文

• AGD1/USP10/METTL13 complexes enhance cancer stem cells proliferation and diminish the therapeutic effect of docetaxel via CD44 m6A modification in castration resistant prostate cancer (2025 · Journal of Experimental & Clinical Cancer Research · 被引 18)
• BCAT2 binding to PCBP1 regulates the PI3K/AKT signaling pathway to inhibit autophagy-related apoptosis and ferroptosis in prostate cancer (2025 · Cell Death and Disease · 被引 14)
• Association of Dietary Selenium Intake with Type 2 Diabetes in Middle-Aged and Older Adults in China (2024 · Nutrients · 被引 14)
• Role of SLC5A2 polymorphisms and effects of genetic polymorphism on sodium glucose cotransporter 2 inhibitors response (2023 · Molecular Biology Reports · 被引 10)
• New perspectives on the treatment of diabetic nephropathy: Challenges and prospects of mesenchymal stem cell therapy (2025 · European Journal of Pharmacology · 被引 7)
• Association between dietary index for gut microbiota and self-reported severe headache or migraine in U.S. adults: a cross-sectional study from NHANES (2025 · Frontiers in Nutrition · 被引 3)